18FDG PET Assessment of Therapeutic Response in Patients with Advanced or Metastatic Melanoma Treated with First-Line Immune Checkpoint Inhibitors

SIMPLE SUMMARY: In a retrospective study of patients with advanced or metastatic melanoma treated with first-line immune checkpoint inhibitors, we investigated the value of metabolic criteria, PERCIST 5 (criteria used for conventional chemotherapy), and imPERCIST5 (criteria adapted for immunotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivas, Alexia, Delyon, Julie, Martineau, Antoine, Blanc, Estelle, Allayous, Clara, Da Meda, Laetitia, Merlet, Pascal, Lebbé, Céleste, Baroudjian, Barouyr, Vercellino, Laetitia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264956/
https://www.ncbi.nlm.nih.gov/pubmed/35804963
http://dx.doi.org/10.3390/cancers14133190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264956/
https://www.ncbi.nlm.nih.gov/pubmed/35804963
http://dx.doi.org/10.3390/cancers14133190

Ejemplares similares